PDCD10 and neoplasm: Consistent with the results from the in vitro experiments, PDCD10 silencing significantly reduced the tumor sizes and weights of xenograft tumors (Att-20 cell line: 0.94±0.07g vs. 0.38±0.06g, and TtT/GF cell line:1.04±0.11g vs. 0.34g±0.12g) (Figures 6A, 5B).